Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk

Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk

Abstract Prostate cancer (PCa) remains a significant global health challenge, with approximately 1.6 million new cases and 366,000 deaths annually. Despite high survival rates for localized prostate cancer, recurrence poses a substantial risk due to inherent biological factors and residual disease....

Full description

Saved in:
Bibliographic Details
Main Authors: Fahad M. Aldakheel, Hadeel Alnajran, Shatha A. Alduraywish, Ayesha Mateen, Mohammed S. Alqahtani, Rabbani Syed
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Discover Oncology
Subjects:
Methylation
Expression
Recurrence
Prostate cancer
Cell lines
Machine learning
Online Access:https://doi.org/10.1007/s12672-025-01833-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-01833-8

Similar Items